Attorney Advertising. The law firm of Wolf Haldenstein Adler Freeman & Herz LLP is investigating possible breaches of fiduciary duty by the Board of Directors of Home Diagnostics, Inc. (“Home Diagnostics” or the “Company”) [NASDAQ:HDIX] arising out of the proposed acquisition of Home Diagnostics by Nipro Corporation (“Nipro”).

On Wednesday, February 3, 2010, Home Diagnostics announced that Nipro will acquire it pursuant to a cash tender offer. Under the terms of the agreement, Home Diagnostics stockholders will receive cash of $11.50 in exchange for each share of Home Diagnostics common stock. However, the Company may not have adequately shopped itself around before entering into this transaction and, pursuant to this proposed transaction, Nipro may be underpaying for Home Diagnostics, thus unlawfully harming Home Diagnostics shareholders.

Wolf Haldenstein has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in U.S. federal and state courts. Please visit the Wolf Haldenstein website ( for more information about the firm.

If you own Home Diagnostics common stock and you wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Gustavo Bruckner or Derek BehnkeWolf Haldenstein Adler Freeman& Herz LLP270 Madison AvenueNew York, New York 10016Phone Numbers: (800) 575-0735(212) 545-4600



Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.

Copyright Business Wire 2010